BioCryst Pharma (BCRX) Options Trade Creates 80K Shares to Buy Following News of H5N1 Bird Flu Fears in Malaysia - Susquehanna

Susquehanna option strategist Alison Edwards notes bullish options activity in BioCryst Pharma (NASDAQ: BCRX), as an opening investor purchased 2000 Apr 9 Calls for $0.62, creating 80,000 shares to buy. The shares are up 10% on heavy volume due to article outling H5N1 Bird Flu fears out of Malaysia.

You May Also Be Interested In

• Ibotta (IBTA) starts trading at $118, price IPO at $88
• Tesla (TSLA) continues to slide, breaks under $150
• Zions Bancorp (ZION) April weekly 39 straddle into quarter results